GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » Market Cap

MDBIF (TrivarX) Market Cap : $4.15 Mil (As of Dec. 14, 2024)


View and export this data going back to 2017. Start your Free Trial

What is TrivarX Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TrivarX's share price for the quarter that ended in Dec. 2023 was $0.015. TrivarX's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 338.08 Mil. Therefore, TrivarX's market cap for the quarter that ended in Dec. 2023 was $5.07 Mil.

TrivarX's quarterly market cap declined from Dec. 2022 ($3.65 Mil) to Jun. 2023 ($3.64 Mil) but then increased from Jun. 2023 ($3.64 Mil) to Dec. 2023 ($5.07 Mil).

TrivarX's annual market cap declined from Jun. 2021 ($10.77 Mil) to Jun. 2022 ($4.00 Mil) and declined from Jun. 2022 ($4.00 Mil) to Jun. 2023 ($3.64 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TrivarX's Enterprise Value for Today is $3.62 Mil.


TrivarX Market Cap Historical Data

The historical data trend for TrivarX's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Market Cap Chart

TrivarX Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.34 10.77 4.00 3.64 6.14

TrivarX Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 3.65 3.64 5.07 6.14

Competitive Comparison of TrivarX's Market Cap

For the Health Information Services subindustry, TrivarX's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TrivarX's Market Cap Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TrivarX's Market Cap distribution charts can be found below:

* The bar in red indicates where TrivarX's Market Cap falls into.



TrivarX Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

TrivarX's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as

Market Cap (A: Jun. 2023 )=Share Price (A: Jun. 2023 )*Shares Outstanding (EOP) (A: Jun. 2023 )
=$0.016*227.396
=$3.64

TrivarX's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=$0.015*338.079
=$5.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TrivarX  (OTCPK:MDBIF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


TrivarX Market Cap Related Terms

Thank you for viewing the detailed overview of TrivarX's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


TrivarX Business Description

Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.

TrivarX Headlines

From GuruFocus

Medibio Receives CE Certification

By Marketwired Marketwired 05-03-2018

Medibio Limited Quarterly ASX Update and Cashflows

By Marketwired Marketwired 10-30-2018

Departure of Managing Director & Chief Executive Officer

By Marketwired Marketwired 08-29-2018

Medibio Launches Global Corporate Mental Health Product

By Marketwired Marketwired 05-01-2018

Receipt of $3,146,835 R&D Tax Incentive Refund

By Marketwired Marketwired 10-15-2018

Medibio Market Update

By Marketwired Marketwired 11-02-2018